European Organisation for Research and Treatment of Cancer - EORTC: Glioblastoma trials

The registry lists 15 Glioblastoma studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 8Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III StudyRecruitingNCT05904119Phase 3
• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed GlioblastomaCompletedNCT03345095Phase 3Results posted
• Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.CompletedNCT03224104Phase 1Results posted
• Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth GlioblastomaWithdrawnNCT04933942Phase 2
• Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in GlioblastomaCompletedNCT03770468
• Bevacizumab and Lomustine for Recurrent GBMCompletedNCT01290939Phase 3
• Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01019434Phase 2
• Epothilone ZK-219477 in Treating Patients With Recurrent GlioblastomaCompletedNCT00424060Phase 2
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00128700Phase 1/2
• Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00086879Phase 2
• Glufosfamide in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00014300Phase 2
• Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00006353Phase 3
• Nitrocamptothecin in Treating Patients With Glioblastoma MultiformeCompletedNCT00005826Phase 2
• Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00004937Phase 2
• Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During SurgeryCompletedNCT00004015Phase 1